CRAIG EAGLE - 08 Feb 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Craig Eagle
Issuer symbol
TELO
Transactions as of
08 Feb 2024
Transactions value $
$0
Form type
3
Filing time
08 Feb 2024, 17:46:28 UTC
Previous filing
03 Jan 2024
Next filing
02 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TELO Common Stock 488K 08 Feb 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.